Maria Nikiforova

10PUBLICATIONS
78CO-AUTHORS
Biologically active moleculesMedical infection agents (incl. prions)VenereologyMedical biotechnology diagnostics (incl. biosensors)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 13, 2026
Dose-Dependent Influence of RBD-Derived Amyloidogenic Peptides on SARS-CoV-2 Infectivity: A Cautionary Tale for Antiviral Design.

|May 26, 2026
[Comparison of candidate vaccines against Tick-borne encephalitis based on mRNA, simian adenovirus serotype 25 and a chimeric replication-competent yellow fever vaccine strain].

|Jan 28, 2026
Development of an mRNA Vaccine for Tick-Borne Encephalitis: Selection of a Prototype Virus Strain.

Maria A Nikiforova, Vladimir A Gushchin, Denis A Kleymenov

|Jun 02, 2023
[Evaluation of the dynamics of detection of viable SARS-CoV-2 (Coronaviridae: Betacoronavirus: Sarbecovirus) in biological samples obtained from patients with COVID-19 in a health care setting, as one of the indicators of the infectivity of the virus].

N A Kuznetsova, D A Ogarkova, V A Gushchin

|Oct 29, 2021
Snake venom phospholipase A2s exhibit strong virucidal activity against SARS-CoV-2 and inhibit the viral spike glycoprotein interaction with ACE2.

Andrei E Siniavin, Maria A Streltsova, Maria A Nikiforova

|Oct 26, 2021
The Value of Rapid Antigen Tests for Identifying Carriers of Viable SARS-CoV-2.

Elena V Shidlovskaya, Nadezhda A Kuznetsova, Elizaveta V Divisenko

Pageof 2

Frequent Collaborators

9 joint publications

Vladimir Gushchin

6 joint publications

Andrei E Siniavin

4 joint publications

Nadezhda A Kuznetsova

3 joint publications

Elena V Shidlovskaya